cyclodextrins an overview matthias arenskötter florence folmer chris llewellyn aurélie pardo frank...
TRANSCRIPT
Cyclodextrins An Overview
Matthias ArenskötterFlorence Folmer
Chris Llewellyn Aurélie PardoFrank ReineckeGrazia Trebbi
Gent 2001
1. Introduction
2. Microbial Production
3. Purification And Fractionation
4. Properties
5. Applications
Cyclodextrins - An Overview
Introduction• Cyclodextrins (CDs) are torus shaped cyclic
oligomers consisting of 6 (),7 () or 8 (-CD) glucose units with -1,4-linkages with a hydrophobic cavity and a hydrophilic exterior
O
CH2OH
OOH
OHO
O
O
CH2OH
O
OH
OH
O
CH2OH
OH
OH
O
CH2OH
OH
OH O
O
CH2OH
O
OH
OH
O
CH2OH
OH
OH
IntroductionHistory:
• 1891 Discovery, Villiers
• 1903 Descriptions of properties, Shardinger
• 1939 Tilden and Hudson were able to show that the conversion of starch to CD was due to the action of an enzyme, CD Glycosyl-Transferase (CGTase), which was secreted into the culture medium.
Introduction• 1957 Complexation ability of CDs widely
accepted; Cramer, French
• 1981 First International Symposium on CDs, Szejtli
• 1987 Total synthesis, Ogawa
• 1994 Total synthesis of cyclo[D-Glcp(1->4)]5
Introduction• Today CDs are only synthesized either by
fermentation or enzymatically.
• Many CGTases from different microorganisms are known, cloned, sequenced, characterized and used for production of CDs.
IntroductionApplications:
• Because of their unique properties CDs allow „packaging on a molecular level“ of various molecules which is applied in pharmaceutics, food and flavours etc...
• Used in chromatographic columns CDs can separate stereoisomers.
• Derivatives of CDs can even be used to mimic enzymes.
1. Introduction
2. Microbial Production
3. Purification And Fractionation
4. Properties
5. Applications
Cyclodextrins - An Overview
Microbial Production• CGTases are produced by many different
bacterial species of the genus Bacillus but also by Flavobacterium sp., Klebsiella pneumoniae and Micrococcus sp.
• Genes have been cloned and recombinantly expressed in Escherichia coli and other organisms, including for example Solanum tuberosum (Potato).
• The CGTase acts on linear starch and transfers a part of the chain (F) to its own non-reducing end (A) as indicated in this model:
Microbial Production
CGTaseA
BC
D
E F G H
starch
A
BC
D
E F G H
-CD
1. Introduction
2. Microbial Production
3. Purification And Fractionation
4. Properties
5. Applications
Cyclodextrins - An Overview
• Enzymatic synthesized CDs are selectively precipitated by organic solvents.
Purification and Fractionation
precipitating agent yield (%)-CD 1-decanol 40-CD toluene 50-60-CD cyclohexadec-8-en-1-ol 40-50
1. Introduction
2. Microbial Production
3. Purification And Fractionation
4. Properties
5. Applications
Cyclodextrins - An Overview
PropertiesImportant Properties:• CDs have hydrophobic cavities of different sizes enabling
the complexation of hydrophic guest molecules.• These complexes represent a solution for insolubility.• They have neither a reducing nor a non-reducing end-group.
PropertiesStability:
• CDs are not decomposed by hot aqueous alkali and rather resistant to acid hydrolysis.
• CDs are resistant to -amylases (except microbial enzymes) and they are completely resistant to yeast-fermentation and -amylases.
Properties
Properties
Molecular weight 972 1135 1297Glucose monomers 6 7 8Internal cavity diameter(angstroms)
4.7-5.3 6.0–6.6 7.5–8.3
Water solubility(g/100mL: 25 deg. C)
14.2 1.85 23.2
Melting range (deg. C) 255-260 255-265 240-245Water of crystallization 10.2 13-15 8-18Water molecules in cavity 6 11 17Cavity volume (ml/mol) 174 262 472Price (US$/g pharma-grade) 1.0 0.025 0.8
1. Introduction
2. Microbial Production
3. Purification And Fractionation
4. Properties
5. Applications
Cyclodextrins - An Overview
ApplicationsPharmaceutical industry:• Treatment of inflammation or throat infection (with iodine)• Coronary dilatation (with nitroglycerin)• Anti-ulcerate (with benexate)• Vectors for vitamins or hormones• Reduction of side-effects and increase in efficiency of anti-cancer drugs
ApplicationsPharmaceutical
industry:
SolidComplex
Dissolution (kd)
Dissolved Complex
Adsorption (ka)
(kc)
CyclodextrinCompeting
Agent
Competing Agent-Cycloddextrin Complex
(ki)
Drug
Drug
Biomembrane
Systemic Circulation
ApplicationsCosmetics & Hygiene:• Long-lasting perfume release• Deodoriser (with peppermint oil, i.e.)• Removal of dryness wrinkles (with seaweed compounds, Vitamin A & E)• Anti-cellulitis compound• Shampoo industry• Teeth cleaning, anti-plaque compound• Antibacterial in refrigerators
ApplicationsFood industry:
• Emulsion stabiliser
• Taste-masking
• Long-lasting flavouring
• Removal of cholesterol from milk, butter, eggs, a.o.
ApplicationsPaint industry:• Increase in compatibility of paint ingredients• Increase in stability of the paint• Increase in the range of colours and in the quality of
dyes
ApplicationsEnvironmental protection:
• Reduction in oxidiser requirements in paper production
• Environmentally friendly oil-spill clean-up
• Treatment of tree-wounds (with auxin)
• Mobilisation of toxins without leaving toxic residues behind (innovative technique)
ApplicationsEnvironmental protection:• Removal or detoxification of waste material, esp.
aromatic pollutants• Use in agriculture to increase the stability and the
efficiency of herbicides, insecticides, repellents,…
ApplicationsChemical and biochemical applications:• Reaction catalyst in adhesives• Use in chromatography (separation of stereoisomers)• Increase in speed of diagnostic test reaction
ApplicationsChemical and biochemical applications:• Enzyme mimicry
Dimer of -cyclodextrin linked on primary side by a metal-binding-group as catalyst of hydrolysis of a phosphate diester
O2N
O
NO2
O
NN
S S
La
O
O
O
P
O
3+
Summary• When Cyclodextrins were discovered they were just a chemical
curiosity but today a lot of applications are known.
• Due to intensive studies and advances in production procedures prices continue to decrease making CDs attractive for many applications.
• To date more than 3300 European Patents are registered indicating great industrial interest.
Group Members• Matthias Arenskötter, Westfälische Wilhelms-
Universität Münster, Germany
• Florence Folmer, University of Wales Bangor, UK
• Chris Llewellyn, University of Wales Swansea, UK
• Aurélie Pardo, Institue Nationale Polytechnique de Toulouse, France
• Frank Reinecke , Westfälische Wilhelms-Universität Münster, Germany
• Grazia Trebbi, Universita´ di Bologna, Italy